Related Experiment Video
Updated: Jan 25, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Young plasma ameliorates aging-related acute brain injury after intracerebral hemorrhage
Jun-Jie Yuan1, Qin Zhang1, Chang-Xiong Gong1
1Department of Neurology, Xinqiao Hospital, The Army Medical University, Third Military Medical University, Chongqing 400037, China.
Insights
Young plasma therapy shows promise for acute brain injury in aging rodents. It reduced mortality and neurological deficits, potentially by increasing insulin-like growth factor 1 (IGF-1) levels, offering a novel therapeutic avenue.
Area of Science:
- Neuroscience
- Gerontology
- Regenerative Medicine
Background:
- Aging impairs brain function and worsens acute brain damage.
- Young plasma has shown potential to reverse age-related decline in biofunctions.
- Intracerebral hemorrhage (ICH) is a severe form of acute brain injury often exacerbated by aging.
Purpose of the Study:
- To investigate the neuroprotective effects of young plasma in aging rodents with ICH.
- To identify circulating factors in young plasma that may mediate these protective effects.
- To explore the role of insulin-like growth factor 1 (IGF-1) in aging-related brain injury and its response to young plasma.
Main Methods:
- Administration of young plasma to aging ICH rodent models.
- Assessment of mortality, neurological deficit scores, brain water content, and neuronal survival.
- Proteomics analysis to identify differential circulating factors between age groups.
- Enzyme-linked immunosorbent assay (ELISA) to quantify IGF-1 levels in plasma and brain tissue.
- Administration of IGF-1 to aging ICH rodents to evaluate its therapeutic effect.
Main Results:
- Young plasma significantly reduced mortality and neurological deficits in aging ICH rodents.
- Proteomics revealed age-dependent changes in plasma factors, with IGF-1 notably decreased in older individuals.
- Young plasma treatment restored decreased brain IGF-1 levels in aging ICH rats.
- Direct administration of IGF-1 ameliorated acute brain injury in aging ICH rodents.
Conclusions:
- Young plasma possesses neuroprotective properties against acute brain injury in aging.
- Circulating factors, particularly IGF-1, transferred via young plasma may exert therapeutic effects.
- Young plasma represents a potential novel therapeutic strategy for age-related acute brain injury.
Abstract:
Aging has been shown to contribute to both the declined biofunctions of aging brain and aggravation of acute brain damage, and the former could be reversed by young plasma. These results suggest that young plasma treatment may also reduce the acute brain damage induced by intracerebral hemorrhage (ICH). In the present study, we first found that the administration of young plasma significantly reduced the mortality and neurological deficit score in aging ICH rodents, which might be due to the decreased brain water content, damaged neural cells, and increased survival neurons around the perihematomal brain tissues. Then, proteomics analysis was used to screen out the potential neuroprotective circulating factors and the results showed that many factors were changed in health human plasma among young, adult, and old population. Among these significantly changed factors, the plasma insulin-like growth factor 1 (IGF-1) level was significantly decreased with age, which was further confirmed both in human and rats detected by ELISA. Additionally, the brain IGF-1 protein level in aging ICH rats was markedly decreased when compared with young rats. Interestingly, the relative decreased brain IGF-1 level was reversed by the treatment of young plasma in aging ICH rats, while the mRNA level was non-significantly changed. Furthermore, the IGF-1 administration significantly ameliorated the acute brain injury in aging ICH rats. These results indicated that young circulating factors, like IGF-1, may enter brain tissues to exert neuroprotective effects, and young plasma may be considered as a novel therapeutic approach for the clinical treatment of aging-related acute brain injury.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

